Arbutus Biopharma Corp Operating Leases, Rent Expense, Net
Arbutus Biopharma Corp (ABUS) reported Operating Leases, Rent Expense, Net of $1.79 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeasesRentExpenseNet · last filed 2019-03-07
CAD
| Period end | Operating Leases, Rent Expense, Net 12 month |
|---|---|
| 2012-12-31 | 936.76K CAD 20-F · filed 2013-03-27 |
| 2011-12-31 | 933.53K CAD 20-F · filed 2013-03-27 |
| 2010-12-31 | 931.61K CAD 20-F · filed 2013-03-27 |
USD
| Period end | Operating Leases, Rent Expense, Net 12 month | Operating Leases, Rent Expense, Net 12 month as first filed |
|---|---|---|
| 2018-12-31 | $1.79M 10-K · filed 2019-03-07 | |
| 2017-12-31 | $1.65M 10-K · filed 2019-03-07 | |
| 2016-12-31 | $1.34M 10-K · filed 2018-03-16 | |
| 2015-12-31 | $1.16M 10-K · filed 2018-03-16 | |
| 2014-12-31 | $1.13M 10-K · filed 2017-03-22 | |
| 2013-12-31 | $1.23M 10-K · filed 2016-03-09 | $1.22M 6-K · filed 2014-03-06 |
| 2012-12-31 | $937.00K 10-K · filed 2015-03-13 | $937.37K 6-K · filed 2014-03-06 |
| 2011-12-31 | $944.46K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |